blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3340787

EP3340787 - TRANSGENIC ANIMAL FOR PRODUCTION OF ANTIBODIES HAVING A COMMON LIGHT CHAIN [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  05.12.2019
Database last updated on 17.05.2024
FormerRequest for examination was made
Status updated on  01.06.2018
FormerThe international publication has been made
Status updated on  04.03.2017
Most recent event   Tooltip05.12.2019Application deemed to be withdrawnpublished on 01.01.2020  [2020/01]
Applicant(s)For all designated states
Crystal Bioscience Inc.
3911 Sorrento Valley Boulevard
Suite 110
San Diego, CA 92121 / US
[2018/27]
Inventor(s)01 / HARRIMAN, William Don
Crystal Bioscience Inc.
5980 Horton Street Suite 405
Emeryville, California 94608 / US
02 / ETCHES, Robert
Crystal Bioscience Inc.
5980 Horton Street Suite 405
Emeryville, California 94608 / US
03 / LEIGHTON, Philip A.
Crystal Bioscience Inc.
5980 Horton Street Suite 405
Emeryville, California 94608 / US
 [2018/27]
Representative(s)AWA Sweden AB
Box 45086
104 30 Stockholm / SE
[N/P]
Former [2018/27]AWA Sweden AB
P.O. Box 45086
104 30 Stockholm / SE
Application number, filing date16840067.924.08.2016
[2018/27]
WO2016US48485
Priority number, dateUS201562210926P27.08.2015         Original published format: US 201562210926 P
[2018/27]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2017035274
Date:02.03.2017
Language:EN
[2017/09]
Type: A1 Application with search report 
No.:EP3340787
Date:04.07.2018
Language:EN
The application published by WIPO in one of the EPO official languages on 02.03.2017 takes the place of the publication of the European patent application.
[2018/27]
Search report(s)International search report - published on:US02.03.2017
(Supplementary) European search report - dispatched on:EP04.12.2018
ClassificationIPC:A01K67/027, A61K39/395
[2018/27]
CPC:
A01K67/0278 (EP,KR,US); C07K16/00 (EP,KR,US); C07K16/46 (US);
C12N15/8509 (EP,KR,US); A01K2217/072 (EP,KR,US); A01K2217/206 (EP,KR,US);
A01K2227/30 (EP,KR,US); A01K2267/01 (EP,KR,US); C07K2317/21 (EP,KR,US);
C07K2317/23 (EP,KR,US); C12N2800/30 (EP,KR,US); C12N2830/40 (EP,KR,US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2018/27]
TitleGerman:TRANSGENES TIER ZUR HERSTELLUNG VON ANTIKÖRPERN MIT EINER GEMEINSAMEN LEICHTEN KETTE[2018/27]
English:TRANSGENIC ANIMAL FOR PRODUCTION OF ANTIBODIES HAVING A COMMON LIGHT CHAIN[2018/27]
French:ANIMAL TRANSGÉNIQUE POUR LA PRODUCTION D'ANTICORPS AYANT UNE CHAÎNE LÉGÈRE COMMUNE[2018/27]
Entry into regional phase27.02.2018National basic fee paid 
27.02.2018Search fee paid 
27.02.2018Designation fee(s) paid 
27.02.2018Examination fee paid 
Examination procedure27.02.2018Examination requested  [2018/27]
27.02.2018Date on which the examining division has become responsible
09.10.2018Amendment by applicant (claims and/or description)
02.07.2019Application deemed to be withdrawn, date of legal effect  [2020/01]
09.08.2019Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2020/01]
Fees paidRenewal fee
10.08.2018Renewal fee patent year 03
Penalty fee
Additional fee for renewal fee
31.08.201904   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[A]US2013045492  (BABB ROBERT [US], et al) [A] 1-16 * the whole document *;
 [A]  - PHILIP A. LEIGHTON ET AL, "A Diverse Repertoire of Human Immunoglobulin Variable Genes in a Chicken B Cell Line is Generated by Both Gene Conversion and Somatic Hypermutation", FRONTIERS IN IMMUNOLOGY, (20150320), vol. 6, doi:10.3389/fimmu.2015.00126, XP055340845 [A] 1-16 * abstract * * page 2 *

DOI:   http://dx.doi.org/10.3389/fimmu.2015.00126
 [AD]  - ELLEN COLLARINI ET AL, "Inserting random and site-specific changes into the genome of chickens", POULTRY SCIENCE, Oxford, (20141020), vol. 94, no. 4, doi:10.3382/ps.2014-04372, ISSN 0032-5791, pages 799 - 803, XP055525563 [AD] 1-16 * abstract *

DOI:   http://dx.doi.org/10.3382/ps.2014-04372
 [AP]  - LEIGHTON PHILIP A ET AL, "Generation of chickens expressing Cre recombinase", TRANSGENIC RESEARCH, SPRINGER NETHERLANDS, NL, vol. 25, no. 5, doi:10.1007/S11248-016-9952-6, ISSN 0962-8819, (20160331), pages 609 - 616, (20160331), XP036055590 [AP] 1-16 * the whole document *

DOI:   http://dx.doi.org/10.1007/s11248-016-9952-6
 [T]  - KATHRYN H. CHING ET AL, "Chickens with humanized immunoglobulin genes generate antibodies with high affinity and broad epitope coverage to conserved targets", MABS, US, (20171102), vol. 10, no. 1, doi:10.1080/19420862.2017.1386825, ISSN 1942-0862, pages 71 - 80, XP055525565 [T] * the whole document *

DOI:   http://dx.doi.org/10.1080/19420862.2017.1386825
International search[X]WO9945962  (GENPHARM INT [US], et al) [X] 22-23 * ; page 31, lines 17-19; page 81, lines 26-28; page 308, line 32-34 *;
 [Y]US2011236378  (GREEN LARRY [US], et al) [Y] 4/3/1-2, 5/3/1-2, 6/3/1-2, 7/6/3/1-2* ; paragraphs [0023], [0061], [0139], [0140], [0146] *;
 [XY]US2014068796  (HARRIMAN WILLIAM DON [US], et al) [X] 1-2, 3/1-2 * ; abstract; paragraphs [0004], [0027], [0072], [0089], [0152], [0155], [0159], [0169] * [Y] 0
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.